Antibiotic treatment outcomes in community-acquired pneumonia
| dc.contributor.author | Çilli A. | |
| dc.contributor.author | Sayiner A. | |
| dc.contributor.author | Çelenk B. | |
| dc.contributor.author | Şakar Coşkun A. | |
| dc.contributor.author | Kilinç O. | |
| dc.contributor.author | Hazar A. | |
| dc.contributor.author | Aktaş Samur A. | |
| dc.contributor.author | Taşbakan S. | |
| dc.contributor.author | Waterer G.W. | |
| dc.contributor.author | Havlucu Y. | |
| dc.contributor.author | Kiliç Ö. | |
| dc.contributor.author | Tokgöz F. | |
| dc.contributor.author | Bilge U. | |
| dc.date.accessioned | 2025-04-10T11:08:16Z | |
| dc.date.available | 2025-04-10T11:08:16Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Background/aim: The optimal empiric antibiotic regimen for patients with community-acquired pneumonia (CAP) remains unclear. This study aimed to evaluate the clinical cure rate, mortality, and length of stay among patients hospitalized with community-acquired pneumonia in nonintensive care unit (ICU) wards and treated with a β-lactam, β-lactam and macrolide combination, or a fluoroquinolone. Materials and methods: This prospective cohort study was performed using standardized web-based database sheets from January 2009 to September 2013 in nine tertiary care hospitals in Turkey. Results: Six hundred and twenty-one consecutive patients were enrolled. A pathogen was identified in 78 (12.6%) patients. The most frequently isolated bacteria were S. pneumoniae (21.8%) and P. aeruginosa (19.2%). The clinical cure rate and length of stay were not different among patients treated with β-lactam, β-lactam and macrolide combination, and fluoroquinolone. Forty-seven patients (9.2%) died during the hospitalization period. There was no difference in survival among the three treatment groups. Conclusion: In patients admitted to non-ICU hospital wards for CAP, there was no difference in clinical outcomes between β-lactam, β-lactam and macrolide combination, and fluoroquinolone regimens. © TÜBİTAK. | |
| dc.identifier.DOI-ID | 10.3906/sag-1709-144 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/47897 | |
| dc.publisher | Turkiye Klinikleri Journal of Medical Sciences | |
| dc.title | Antibiotic treatment outcomes in community-acquired pneumonia | |
| dc.type | Article |